Women's Health: Consequences of Human Egg Donation

Testimony of Pia de Solenni before the Massachusetts State Legislature’s Joint Committee on Economic Development and Emerging Technologies     FRC’s Director of Life and Women’s Issues Pia de Solenni, Ph.D. gave the following testimony before the Massachusetts State Legislature’s Joint Committee on Economic Development and Emerging Technologies regarding adult stem cell research and embryonic stem cell research on February 16, 2005. I am Dr. Pia de Solenni, director of life and women’s issues at the Family Research Council in Washington, DC. I speak to you today as an ethicist who has researched adult stem cell research and embryonic stem cell research from many perspectives. Let’s take a moment to examine where we’re at in the cloning debate. While reproductive cloning has been removed from center stage, the focus on so-called therapeutic cloning continues to grow. At the same time, little attention has been given to advances in adult stem cell research. I would ask that these two research binders be included in the record of today’s testimony. This one represents a fraction of the advances in human adult stem cell research just for 2004. Over 30 peer-reviewed studies are included. Many more are available. This other binder, you will note, is curiously empty. It contains treatments from human embryonic stem cell research. After more than 20 years, cloning and embryonic stem cell research have not yielded a single cure. The hype is not unlike that surrounding the debates about the rain forest and fetal tissue research during the 1990s. I also include a letter from June 18, 2004, written on behalf of Dr. Elias Zerhouni at the National Institutes of...